Prenetics Global Limited (PRENW)
- Previous Close
0.0099 - Open
0.0092 - Bid --
- Ask --
- Day's Range
0.0092 - 0.0140 - 52 Week Range
0.0092 - 0.0140 - Volume
200,790 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-11.0410 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally. The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions under Prevention segment.; and ACT Genomics that provides precision oncology testing services under the Diagnostics segment. In addition, it develops and commercializes multi-cancer early detection technologies. Further, the company offers a range of genomic profiling panels tailored for requirements and clinician needs. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
www.prenetics.comRecent News: PRENW
View MoreCompare To: PRENW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRENW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-151.22%
Return on Assets (ttm)
-13.50%
Return on Equity (ttm)
-26.12%
Revenue (ttm)
30.62M
Net Income Avi to Common (ttm)
-46.33M
Diluted EPS (ttm)
-11.0410
Balance Sheet and Cash Flow
Total Cash (mrq)
63.38M
Total Debt/Equity (mrq)
3.37%
Levered Free Cash Flow (ttm)
-9.9M